← All companies

AXGN

Axogen, Inc.

AXGN Nasdaq Electromedical & Electrotherapeutic Apparatus EDGAR ↗

$45.73

+4.38 +10.59%

Key statistics

from XBRL data in SEC filings

Market cap

$2.46B

Revenue (TTM)

$251M

Net income (TTM)

-$33.5M

EPS (TTM)

$-0.68

P/E ratio

—

Dividend yield

—

Free cash flow

-$2.93M

Cash

$94.6M

Total assets

$305M

Gross margin

74.6%

52-week range

$12.75 – $46.95

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 29, 2026 8-K Shareholder vote results Jun 23, 2026 10-Q Quarter ended 2026-03-31 Apr 28, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 24, 2026 8-K Entered a material agreement; Other events Jan 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Director or officer change Dec 5, 2025 8-K Regulation FD disclosure; Other events Dec 4, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 29, 2025 8-K Regulation FD disclosure Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 5, 2025 8-K Shareholder vote results Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Director or officer change May 8, 2025 8-K Regulation FD disclosure Apr 7, 2025 8-K Regulation FD disclosure Mar 4, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 10, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 8-K Regulation FD disclosure Sep 6, 2024 8-K Director or officer change; Regulation FD disclosure Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K/A Shareholder vote results Jun 10, 2024 8-K Director or officer change; Shareholder vote results Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 2, 2024 8-K Director or officer change Mar 8, 2024 8-K Regulation FD disclosure Mar 5, 2024 10-K Fiscal year ended 2023-12-31 Mar 5, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 5, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K/A Director or officer change Jan 5, 2024